Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-08-15 | New | $313,297,440 | Unknown | Equity Only | SEC link | |
2023-07-27 | Amended | $361,794,505 | $91,249,944 | Equity Only | 06b | SEC link |
2022-05-24 | New | $270,544,561 | $270,544,561 | Equity Only | 06b | SEC link |
2021-07-14 | New | $99,999,999 | Unknown | Equity Only | SEC link | |
2020-08-18 | Amended | $87,634,885 | $1,999,999 | Equity Only | 06b | SEC link |
2020-05-19 | New | $85,634,886 | $85,634,886 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Daniel Chen | Executive |
Katherine Eade | Executive |
Brian Furmanski | Executive |
Ryan Gallagher | Director |
Trit Garg | Director |
Curt Herberts | Executive |
Roger Jeffs | Director |
Dana Johnson | Executive |
Ilise Lombardo | Executive |
Keith Manchester | Director |
James Momtazee | Director |
Ilan Oren | Director |
Britt Petty | Executive |
Akshay Rai | Director |
Saira Ramasastry | Director |
Shankar Ramaswamy | Director, Executive |
Neera Ravindran | Executive |
C.R. Sincock | Director |
Michele Stone | Executive |
Neelaksh Varshney | Director |